Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iris”

328 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 328 results

Testing effectiveness (Phase 2)Study completedNCT00238329
What this trial is testing

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Barbara Ann Karmanos Cancer Institute 32
Not applicableNot Yet RecruitingNCT06408701
What this trial is testing

Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With Ocular Malformations

Who this might be right for
Eye Abnormalities
University Hospital, Toulouse 20
Early research (Phase 1)Study completedNCT00295828
What this trial is testing

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Who this might be right for
Iris NeovascularizationDiabetic Retinopathy
Hermann Eye Center 10
Testing effectiveness (Phase 2)Study completedNCT00005815
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00121225
What this trial is testing

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
National Cancer Institute (NCI) 32
Not applicableStudy completedNCT03120026
What this trial is testing

Improving Rehabilitation In Sarcopenia (IRIS)

Who this might be right for
Sarcopenia
Azienda di Servizi alla Persona di Pavia 140
Not applicableNot Yet RecruitingNCT06588816
What this trial is testing

The Correlation Between Pupil Size and Retinal Nerve Fibers Changes in Pseudoexfoliation Syndrome.

Who this might be right for
Pseudoexfoliation Syndrome
Assiut University 33
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableStudy completedNCT00456664
What this trial is testing

CMV Disease and IRIS in HIV-1 Infected Persons

Who this might be right for
HIV InfectionsCytomegalovirus
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586
What this trial is testing

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 210
Testing effectiveness (Phase 2)Study completedNCT02647359
What this trial is testing

Study of Ataluren in Participants With Nonsense Mutation Aniridia

Who this might be right for
Aniridia
PTC Therapeutics 39
Not applicableLooking for participantsNCT06906627
What this trial is testing

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Who this might be right for
Chronic Kidney Disease(CKD)Type 2 DMType 2 Diabetes Mellitus (T2DM)
Duke University 750
Testing effectiveness (Phase 2)Study completedNCT00027742
What this trial is testing

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00485108
What this trial is testing

Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty

Who this might be right for
Primary Open Angle GlaucomaPseudoexfoliation Glaucoma
Queen's University 120
Not applicableActive Not RecruitingNCT04632784
What this trial is testing

Clinical Trial With Artiflex Presbyopic (Artiplus)

Who this might be right for
PresbyopiaAmetropiaRefractive Errors+2 more
Ophtec BV 49
Not applicableStudy completedNCT01348399
What this trial is testing

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

Who this might be right for
Coronary Artery Disease
Seung-Jung Park 2,000
Not applicableStudy completedNCT05614622
What this trial is testing

Mydriatic Drops After Combined Surgery

Who this might be right for
Posterior Synechiae of Iris
Rabin Medical Center 60
Large-scale testing (Phase 3)Study completedNCT01126203
What this trial is testing

Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension

Who this might be right for
Exfoliation SyndromeOcular Hypertension
University of Calgary 25
Large-scale testing (Phase 3)Ended earlyNCT01564095
What this trial is testing

TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion

Who this might be right for
Terminal Liver DiseaseIschemia Reperfusion InjuryGraft Dysfunction+2 more
Ludwig-Maximilians - University of Munich 25
Testing effectiveness (Phase 2)WithdrawnNCT05255666
What this trial is testing

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Who this might be right for
Triple Negative Breast CancerBrain Metastases
Washington University School of Medicine
Load More Results